Duke's leukemia doctors work as a team to detect and treat leukemia, which occurs when the white blood cells produced in the bone marrow do not mature normally. The abnormal cells prevent the body from making healthy blood cells and can't fight infection. Our board-certified specialists provide personalized care to people with all types of leukemia including:
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML)
- Hairy cell leukemia (HCL)
- Myelodysplastic syndrome (MDS)
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
We plan a comprehensive treatment strategy for you that uses the most advanced therapies, including many that were developed right here at Duke. Our goal is to give you the personalized care you need to bring you back to good health and maximize your quality of life.
Duke Health offers locations throughout the Triangle. Find one near you.
Cancers are due to genetic changes occurring in a normal cell. These genetic changes pinpoint your specific diagnosis, and determine your treatment needs
Removes a small amount of tissue for examination under a microscope and for additional testing. A biopsy is required for a definitive diagnosis, and may also be used to determine if cancer has spread to the lymph nodes, lungs, liver, or elsewhere.
MRI, PET and CT Scans
These imaging scans help us diagnose your leukemia and recommend the best treatment plan.
Why Choose Duke
Largest Leukemia Center in North Carolina
We treat nearly 1,000 patients with blood cancers each year, more than any other facility in North Carolina. In addition, as a National Cancer Institute-designated Comprehensive Cancer Center, we are recognized as meeting rigorous standards for laboratory, clinical, and population-based research, and for focusing our scientific efforts on developing new and better ways to prevent, diagnose, and treat cancer. We are also part of the National Comprehensive Cancer Network (NCCN), an alliance of the nation’s leading cancer centers dedicated to improving patient care.
Team of Leukemia Specialists
Our team includes hematologic, medical, radiation and surgical oncologists, a well as dermatologists, palliative care, psychologists, infectious disease doctors, radiologists, specially trained nurses, nutritionists, and social workers. They meet regularly to discuss your condition, collect opinions, and offer advanced medical and follow-up care.
Pioneering Leukemia Treatment Options
Novel techniques, such as less intensive chemotherapy prior to a stem cell transplant, were pioneered in part at Duke, and now offer new hope to people with leukemia. We were a part of a national study that determined people with chronic myeloid leukemia (CML) taking imatinib (Gleevec) can expect to have long-term survival compared to those with traditional interferon-alpha therapy, which is now used at many medical centers across the country.
Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm
Recently, BPDCN was recognized as an uncommon subtype of acute myeloid leukemia (AML). Treatment may include the only FDA-approved agent (brand name Elzonris) or a stem cell transplant. Therapies may also be available through clinical trials.
Clinical Trial Access
You may be eligible to participate in clinical trials of new targeted therapies and ways to minimize common cancer-related symptoms before they become widely available at other hospitals.
Support for You and Your Loved Ones
Our comprehensive cancer support services range from helping to minimize the side effects of treatment, to coping with the emotional and psychological effects of diagnosis and treatment. These services include nutrition counseling, palliative care, guided imagery, anxiety control, and meditation. Our cancer survivorship clinic pulls together a range of resources specially designed to help survivors after treatment ends. You can view all of our cancer support groups in our event calendar.
Where you receive your cancer care is important. Duke University Hospital's cancer program is ranked among the nation's best by U.S. News & World Report for 2019–2020.